How Does AVEO Pharmaceuticals (AVEO) Stock Score After 45.6% Move?

Thursday, March 28, 2019 10:17 AM | Brad Spears

AVEO Pharmaceuticals, Inc. (AVEO) stock jumped 45.6% Wednesday, rising as high as $1.02, which is 79% higher than Tuesday’s closing price of $0.57. AVEO stock has fallen -76.37% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy.

Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AVEO stock a score of 44 out of a possible 100. That score is primarily influenced by a long-term technical score of 1. AVEO's score also includes a short-term technical score of 63. The fundamental score for AVEO stock is 66.

In addition to the average rating from Wall Street analysts, AVEO stock has a mean target price of $1.75. This means analysts expect the stock to climb 153.62% over the next 12 months.

What's Happening with AVEO Stock Today

AVEO Pharmaceuticals, Inc. (AVEO) stock is lower by -16.83% while the S&P 500 is up 0.28% as of 10:08 AM on Thursday, Mar 28. AVEO stock has fallen -$0.14 from the previous closing price of $0.83 on volume of 5,923,585 shares. Over the past year the S&P 500 has gained 7.68% while AVEO has fallen -76.37%. AVEO stock lost -$0.05 per share in the over the last 12 months.

Get more analysis and trade ideas on AVEO Pharmaceuticals, Inc. (AVEO) stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

40% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 57% with annual

InvestorsObserver Premium

$ 20.75 $ 12.45 /month
$249 $149.40 billed annually

You May Also Like

Related Articles

Affordable Stocks Trading at New Highs

The Dogs Come up a Little Short in 2019

Cronos Group (CRON) Stock: How Does it Score?

Lipocine (LPCN) Stock: What's Next?

Novus Therapeutics (NVUS) Stock Falls -18.6%: How Does it Score?

What's Next for Cronos Group (CRON) Stock?

Related Companies